Therapeutic efficacy of computerized cognitive remediation therapy on cognitive function, inflammatory biomarkers, and brain structure in patients with amnestic mild cognitive impairment and Alzheimer's disease: A randomized controlled trial
{{output}}
Cognitive and behavioral impairments in Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI) represent significant neuropsychiatric challenges. This randomized controlled trial evaluated a 6-month computerized cognitive remediation therapy (... ...
